Compulsory licensing and access to medicines: TRIPS amendment allows export to least-developed countries

By Abbas M, Riaz S.

Abstract

On 23 January 2017, the TRIPS Agreement was amended to improve access to affordable medicines for developing countries lacking drug manufacturing capacity (IP WATCH; WTO, TRIPS: 23 January 2017 News Items). The new Article 31bis replaces a temporary waiver that gave effect to Paragraph 6 of the Doha Declaration. …read more

Source:: Journal of Intellectual Property Law & Practice